Baudax Bio, Inc.
BXRXDelisted Feb 15, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001780097
Baudax Bio, Inc. was delisted on Feb 15, 2024; its insiders filed their last Form 4 on Dec 19, 2022; 15 institutions reported holding it in 13F filings for Q3 2023, worth $74.5K in total; no superinvestor held it.
13F holders, Q2 2022
Institutional positions in Baudax Bio, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- +1 vs. Q1 2022
- Shares held
- 1.28M
- +30.4K (+2.4%) vs. Q1 2022
- Total value
- $1.08M
- −$1.12M (−51.0%) vs. Q1 2022
- New holders
- 5
- 5 more added
- Sold out
- 4
- 5 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BXRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 1 | $0 |
| Q2 2025 | 1 | $0 |
| Q1 2025 | 1 | $0 |
| Q4 2024 | 1 | $0 |
| Q3 2024 | 1 | $0 |
| Q2 2024 | 1 | $0 |
| Q1 2024 | 1 | $0 |
| Q4 2023 | 2 | $0 |
| Q3 2023 | 15 | $74.5K |
| Q2 2023 | 12 | $152.0K |
| Q1 2023 | 12 | $127.0K |
| Q4 2022 | 10 | $73.2K |
| Q3 2022 | 22 | $352.0K |
| Q2 2022 | 22 | $1.08M |
| Q1 2022 | 21 | $2.20M |
| Q4 2021 | 33 | $2.78M |
| Q3 2021 | 31 | $4.12M |
| Q2 2021 | 39 | $5.58M |
| Q1 2021 | 38 | $9.43M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Baudax Bio, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Alyeska Investment Group, L.P. | 460,000 | $389.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 320,170 | $271.0K | 0.00% | +82,870+34.9% | Added |
| Walleye Capital LLC | 195,095 | $165.0K | 0.00% | +195,095 | New |
| Geode Capital Management, LLC | 65,577 | $55.0K | 0.00% | +6,027+10.1% | Added |
| Vanguard Group Inc | 59,381 | $50.0K | 0.00% | −66,951−53.0% | Reduced |
| Sabby Management, LLC | 47,117 | $40.0K | 0.07% | +28,217+149.3% | Added |
| Warberg Asset Management LLC | 34,500 | $29.0K | 0.01% | 00.0% | Unchanged |
| BlackRock Inc. | 31,916 | $27.0K | 0.00% | −7,414−18.9% | Reduced |
| HRT Financial LP | 23,323 | $19.0K | 0.00% | +23,323 | New |
| Virtu Financial LLC | 20,504 | $17.0K | 0.00% | +20,504 | New |
| Tower Research Capital LLC (TRC) | 7,014 | $6.00K | 0.00% | +4,444+172.9% | Added |
| UBS Group AG | 7,135 | $6.00K | 0.00% | +7,135 | New |
| Ikarian Capital, LLC | 2,966 | $3.00K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 860 | $1.00K | 0.00% | −457−34.7% | Reduced |
| Advisor Group Holdings, Inc. | 1,200 | $1.00K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 30 | $0 | 0.00% | −727−96.0% | Reduced |
| JPMorgan Chase & Co | 14 | $0 | 0.00% | −130−90.3% | Reduced |
| Wells Fargo & Company | 45 | $0 | 0.00% | +28+164.7% | Added |
| Group One Trading, L.P. | 213 | $0 | 0.00% | 00.0% | Unchanged |
| Steward Partners Investment Advisory, LLC | 14 | $0 | 0.00% | 00.0% | Unchanged |
| Sittner & Nelson, LLC | 45 | $0 | 0.00% | 00.0% | Unchanged |
| CoreCap Advisors, LLC | 5 | $0 | 0.00% | +5 | New |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −234,971−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −13,135−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −10,563−100.0% | Sold out |
| Edmond de Rothschild Holding S.A. | 0 | $0 | 0.00% | −2,857−100.0% | Sold out |